IRCT2016020426360N1已完成1 期
The effects of dorzolamide nanoliposomes in comparison with marketed dosage form on intraocular pressure in open angle glaucoma patients
Vice chancellor for research of Ahvaz Jundishapur University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 80 years（—）
- 性别
- All
入选标准
- •patients must use only one drug to reduce their intraocular pressure.
- •Exclusion criteria: patients that have hypertension, diabetes , autoimune disease or chronic disease.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Study of the association of docetaxel and liposomial doxorubicin Myocet in metastatic breast cancer phase II clinical trial - NDEUCTR2006-000120-14-ITAZIENDA USL 6 LIVORNO ZONA LIVORNESE41
招募中
2 期
Clinical study of topical nanoliposome formulation of ruxolitinib 1.5% in treatment of eczemaAtopic dermatitis.Atopic dermatitisIRCT20161207031288N9Tehran University of Medical Sciences20
已完成
早期 1 期
Efficacy of Topical Liposomal Glucantime or Paromomycin in Combination With Systemic Glucantime for the Treatment of ACProtozoal diseases.Cutaneous LeishmaniasisIRCT138809051475N4Mashhad University of Medical sciences30
进行中（未招募）
不适用
Temozolomide and pegylated (PEG)-liposomal Doxorubicin in first line treatment of patients with Glioblastoma WHO Grad IVEUCTR2006-001375-38-ATKlinik und Poliklinik für Neurologie der Universität Regensburg am Bezirksklinikum50
已完成
2 期
Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast CancerBreast CancerNCT00960336ARCAGY/ GINECO GROUP59